Sep 24 |
Milestone Pharmaceuticals to Host Investor KOL Event
|
Sep 6 |
Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China
|
Sep 4 |
Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors
|
Sep 3 |
Milestone® Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
Aug 26 |
Milestone® Pharmaceuticals to Present Data on Etripamil at the ESC Congress 2024
|
Aug 22 |
Milestone wins Buy at Rodman & Renshaw on potential Cardamyst approval
|
Aug 9 |
Milestone Pharmaceuticals GAAP EPS of -$0.14
|
Jul 31 |
Milestone® Pharmaceuticals to Present at the Upcoming BTIG Virtual Biotechnology Conference
|
Jul 15 |
Milestone Pharmaceuticals Refreshes Board of Directors
|
Jun 12 |
Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspectives on PSVT in the Community Setting” on June 20, 2024
|